Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
Madlen JentzschJuliane GrimmMarius BillJohannes KüpperDonata BackhausDominic BrauerJulia SchulzGeorg-Nikolaus FrankeVladan VucinicDietger NiederwieserUwe PlatzbeckerSebastian SchwindPublished in: Bone marrow transplantation (2021)